Phase III PAOLA-1/ENGOT-OV25 Trial: Olaparib Plus Bevacizumab (BEV) As Maintenance Therapy in Patients (PTS) with Newly Diagnosed, Advanced Ovarian Cancer (OC) Treated with Platinum-Based Chemotherapy (PCH) Plus Bev - De Gregorio, Nikolaus; Harter, Philipp; Sehouli, Lalid; Canzler, Ulrich; Marme, Frederik; Buderath, Paul; Lueck, Hans-Joachim; Gropp-Meier, Martina; Runnebaum, Ingo B.; Belau, Antje; Renner, Stefan; Schmalfeldt, Barbara; et al. (ONCOLOGY RESEARCH AND TREATMENT, 2020)
CRIS-Team WoS Importer:2020-03-20